Danish biotech company ups outlook after cancer drug approval by US FDA

November 19, 2015 by · Comments Off on Danish biotech company ups outlook after cancer drug approval by US FDA 

COPENHAGEN, Nov. 18 — The Danish biotech company Genmab on Tuesday raised its financial guidance for the year 2015 after having received approval for its cancer drug Darzalex by the US Food and Drug Administration (FDA).

Read more